IP Library Granted Patent US 9,855,334
Granted Patent B2
US 9,855,334 · App. 15/068,428 · Granted Jan 2, 2018

Topical compositions comprising a corticosteroid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,855,334
App. No.
15/068,428
Granted
Jan 2, 2018
Kind
B2
Abstract

Topical compositions comprising a corticosteroid and at least one penetration enhancing agent, wherein the composition is substantially free of propylene glycol.

Claims (23)

1. A topical cream composition comprising:

between 0.015% and 0.035% (w/w) clobetasol, at least 60% (w/w) water, at least one penetration enhancing agent comprising diethylene glycol monoethyl ether, and at least one alcohol selected from the group consisting of fatty alcohols, PEGylated fatty alcohols, long chain alcohols, isopropyl alcohol, benzyl alcohol, branched aliphatic alcohols, lanolin alcohol, polyvinyl alcohols, and combinations thereof;

wherein the composition is free of propylene glycol.

2. The composition of claim 1 , wherein the clobetasol is clobetasol propionate.

3. The composition of claim 1 is an oil-in-water emulsion.

4. A topical cream composition comprising between 0.015% and 0.035% (w/w) clobetasol propionate, at least 60% (w/w) water, between 0.01% and 15% diethylene glycol monoethyl ether, and at least one alcohol selected from the group consisting of fatty alcohols, PEGylated fatty alcohols, long chain alcohols, isopropyl alcohol, benzyl alcohol, branched aliphatic alcohols, lanolin alcohol, polyvinyl alcohols, and combinations thereof;

wherein the composition is free of propylene glycol.

5. The composition of claim 1 , wherein the at least one alcohol comprises at least one fatty alcohol.

6. The composition of claim 1 , wherein the at least one alcohol comprises at least one PEGylated fatty alcohol.

7. The composition of claim 1 , wherein the at least one alcohol comprises at least one long chain alcohol.

8. The composition of claim 1 , wherein the at least one alcohol comprises isopropyl alcohol.

9. The composition of claim 1 , wherein the at least one alcohol comprises benzyl alcohol.

10. The composition of claim 1 , wherein the at least one alcohol comprises at least one branched aliphatic alcohol.

11. The composition of claim 1 , wherein the at least one alcohol comprises lanolin alcohol.

12. The composition of claim 1 , wherein the at least one alcohol comprises at least one polyvinyl alcohol.

13. The composition of claim 4 , wherein the at least one alcohol comprises at least one fatty alcohol.

14. The composition of claim 4 , wherein the at least one alcohol comprises at least one PEGylated fatty alcohol.

15. The composition of claim 4 , wherein the at least one alcohol comprises at least one long chain alcohol.

16. The composition of claim 4 , wherein the at least one alcohol comprises isopropyl alcohol.

17. The composition of claim 4 , wherein the at least one alcohol comprises benzyl alcohol.

18. The composition of claim 4 , wherein the at least one alcohol comprises at least one branched aliphatic alcohol.

19. The composition of claim 4 , wherein the at least one alcohol comprises lanolin alcohol.

20. The composition of claim 4 , wherein the at least one alcohol comprises at least one polyvinyl alcohol.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2021
From: ENCORE DERMATOLOGY, INC.
To: PRIMUS PHARMACEUTICALS, INC.
Reel/Frame 055576/0523 →
SECURITY INTEREST Recorded Nov 11, 2020
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: PENNRX VENTURES, LLC
Reel/Frame 054337/0330 →
SECURITY INTEREST Recorded Apr 22, 2019
From: ENCORE DERMATOLOGY, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 048958/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2018
From: PROMIUS PHARMA, LLC
To: ENCORE DERMATOLOGY, INC.
Reel/Frame 047740/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2017
From: KANDAVILLI, SATEESH; BOMMAGANI, MADHUSUDHAN; NALAMOTHU, VIJENDRA; OKUMU, FRANKLIN; CHARI, AMALAVOYAL RAGHAV
To: PROMIUS PHARMA LLC
Reel/Frame 044020/0624 →